Arbaz 60mg Injection

Arbaz 60mg Injection is used to treat advanced prostate cancer in adults, belongs to the group of medicines called antineoplastics. It works by stopping the formation of cancer cells in the body. The medication contains an active ingredient Cabazitaxel which is primary used to treat hormone-refractory (castration- resistant) prostate cancer. It inhibits microtubule disassembly which prevent cancer cells from dividing and leading to and leads to cell death. Doctor guidance is required to close monitor the blood counts, liver function and kidney function to ensure safe and effective treatment option.

Prostate cancer

● Anemia
● Low white blood cell count
● Low platelet count
● Fatigue and nausea
● Loose or watery stools
● Blood in urine
● Breathing problems
● Weakness
● Back pain
● Hair loss

Arbaz 60mg Injection is an anticancer medication which should be taken on 60mg Injection with food at the fixed time everyday. Taking it in the wrong way or taking too much may cause serious side effects, consult with the doctor for proper dosage and duration of the medication. It may take several weeks or months to get most benefit but consistency is key.

Prostate gland is a part of the male reproductive system, located below the bladder in the pelvic region of abdomen. It produces the fluid called seminal fluid that nourishes and transports sperm in males. Arbaz 60mg Injection blocks the pathway of microtubule disassembly in cancer cells, preventing their division and growth, thereby inhibiting the progression of prostate cancer.

• Omer, A. B., Altayb, H. N., Al-Abbasi, F. A., Gupta, G., Ahmed, M. M., Alghamdi, A. M., ... & Kazmi, I. (2023). Acemannan ameliorates STZ-activated diabetes by attenuating high glucose via inhibiting inflammatory cytokines and apoptosis pathway. International Journal of Biological Macromolecules, 253, 127127.
• Saifi, M. A., Shaikh, A. S., Kaki, V. R., & Godugu, C. (2022). Disulfiram prevents collagen crosslinking and inhibits renal fibrosis by inhibiting lysyl oxidase enzymes. Journal of Cellular Physiology, 237(5), 2516-2527.
• Schaller, G., Kolodjaschna, J., Pleiner, J., Mittermayer, F., Kapiotis, S., Schmetterer, L., & Wolzt, M. (2008). Pioglitazone does not affect vascular or inflammatory responses after endotoxemia in humans. Hormone and metabolic research, 40(08), 549-555.
• Luksch, A., Rainer, G., Koyuncu, D., Ehrlich, P., Maca, T., Gschwandtner, M. E., ... & Schmetterer, L. (2005). Effect of nimodipine on ocular blood flow and colour contrast sensitivity in patients with normal tension glaucoma. British journal of ophthalmology, 89(1), 21-25.
• Ahmad, A. O., Mohanty, P. K., & Yadav, P. K. (2024). Review on Epcoritamab: A New FDA-Approved Medicine for Adult Patients with Refractory or Relapsed Diffuse Large B-Cell Lymphoma. International Journal of Research in Pharmacy and Allied Science, 3(1), 91-103.